Wechselwirkungen · Samsca
Samsca 7.5 mg tablets Samsca 15 mg tablets Samsca 30 mg tablets · Abschnitt 4.5 · PDF-Seite 6
HOS-209925 · Präparat HOS-154407
There is no experience from controlled clinical trials with concomitant use of Samsca and other treatments for hyponatremia such as hypertonic sodium chloride solution, oral sodium formulations, and medicinal products that increase serum sodium concentration. Medicinal products with high sodium content such as effervescent analgesic preparations and certain sodium containing treatments for dyspepsia may also increase serum sodium concentration. Concomitant use of Samsca with other treatments for hyponatremia or other medicinal products that increase serum sodium concentration may result in a higher risk for developing rapid correction of serum sodium (see section 4.4) and is therefore not recommended during initial treatment or for other patients with very low baseline serum sodium concentrations where rapid correction may represent a risk for osmotic demyelination (see section 4.4).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): sodium (HOS-109681) sodium chloride (HOS-150360)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-20T16:11:00Z · SHA-256 5574073b9385d0a0abc476040d23f65049ec17111a8b63f2d4c4c0ac68807fc8 · Passage 308b2714f322ad2a8f1fe848b4e20b0cdc2fde07b03c76559c2b4b362928681e · Zeichen 122–1018 im Abschnitt